These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 26881972)

  • 1. Sample size determination with familywise control of both type I and type II errors in clinical trials.
    Wang B; Ting N
    J Biopharm Stat; 2016; 26(5):951-65. PubMed ID: 26881972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Step-up testing procedure for multiple comparisons with a control for a latent variable model with ordered categorical responses.
    Lin Y; Kwong KS; Cheung SH; Poon WY
    Stat Med; 2014 Sep; 33(21):3629-38. PubMed ID: 24757077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiplicity-adjusted sample size requirements: a strategy to maintain statistical power with Bonferroni adjustments.
    Leon AC
    J Clin Psychiatry; 2004 Nov; 65(11):1511-4. PubMed ID: 15554764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptive extensions of a two-stage group sequential procedure for testing primary and secondary endpoints (II): sample size re-estimation.
    Tamhane AC; Wu Y; Mehta CR
    Stat Med; 2012 Aug; 31(19):2041-54. PubMed ID: 22733687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple comparisons with two controls for ordered categorical responses.
    Yang P; Hung Cheung S; Poon WY
    J Biopharm Stat; 2017; 27(1):111-123. PubMed ID: 26881877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adding new experimental arms to randomised clinical trials: Impact on error rates.
    Choodari-Oskooei B; Bratton DJ; Gannon MR; Meade AM; Sydes MR; Parmar MK
    Clin Trials; 2020 Jun; 17(3):273-284. PubMed ID: 32063029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using prior information to allocate significance levels for multiple endpoints.
    Westfall PH; Krishen A; Young SS
    Stat Med; 1998 Sep; 17(18):2107-19. PubMed ID: 9789917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A note on familywise error rate for a primary and secondary endpoint.
    Proschan MA; Follmann DA
    Biometrics; 2023 Jun; 79(2):1114-1118. PubMed ID: 35355244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiplicity in multiple regression: Defining the issue, evaluating solutions, and integrating perspectives.
    Anderson SF
    Psychol Methods; 2023 Dec; 28(6):1223-1241. PubMed ID: 35588079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The fallback procedure for evaluating a single family of hypotheses.
    Wiens BL; Dmitrienko A
    J Biopharm Stat; 2005; 15(6):929-42. PubMed ID: 16279352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On generalized fixed sequence procedures for controlling the FWER.
    Qiu Z; Guo W; Lynch G
    Stat Med; 2015 Dec; 34(30):3968-83. PubMed ID: 26228241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An optimised multi-arm multi-stage clinical trial design for unknown variance.
    Grayling MJ; Wason JMS; Mander AP
    Contemp Clin Trials; 2018 Apr; 67():116-120. PubMed ID: 29474933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in p-Value Based Multiple Test Procedures.
    Tamhane AC; Gou J
    J Biopharm Stat; 2018; 28(1):10-27. PubMed ID: 29072552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An extended sequential goodness-of-fit multiple testing method for discrete data.
    Castro-Conde I; Döhler S; de Uña-Álvarez J
    Stat Methods Med Res; 2017 Oct; 26(5):2356-2375. PubMed ID: 26265767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the impact of efficacy stopping rules on the error rates under the multi-arm multi-stage framework.
    Blenkinsop A; Parmar MK; Choodari-Oskooei B
    Clin Trials; 2019 Apr; 16(2):132-141. PubMed ID: 30648428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiplicity and flexibility in clinical trials.
    Brannath W; Koenig F; Bauer P
    Pharm Stat; 2007; 6(3):205-16. PubMed ID: 17674349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlling the family-wise error rate in multi-arm, multi-stage trials.
    Crouch LA; Dodd LE; Proschan MA
    Clin Trials; 2017 Jun; 14(3):237-245. PubMed ID: 28545335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Power and sample size when multiple endpoints are considered.
    Senn S; Bretz F
    Pharm Stat; 2007; 6(3):161-70. PubMed ID: 17674404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal conditional error functions for the control of conditional power.
    Brannath W; Bauer P
    Biometrics; 2004 Sep; 60(3):715-23. PubMed ID: 15339294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A less conservative method to adjust for familywise error rate in neuropsychological research: the Holm's sequential Bonferroni procedure.
    Eichstaedt KE; Kovatch K; Maroof DA
    NeuroRehabilitation; 2013; 32(3):693-6. PubMed ID: 23648625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.